These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 350498)
1. Clinical therapeutic evaluation of methylcysteine hydrochloride in patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control. Aylward M; Bater PA; Davies DE; Hutchings LA; Lewis PA; Maddock J; Protheroe DA Curr Med Res Opin; 1978; 5(6):461-71. PubMed ID: 350498 [TBL] [Abstract][Full Text] [Related]
2. Treatment of stable chronic bronchitis with iodinated glycerol: a double-blind, placebo-controlled trial. Repsher LH J Clin Pharmacol; 1993 Sep; 33(9):856-60. PubMed ID: 8227484 [TBL] [Abstract][Full Text] [Related]
3. Sodium thiophene carboxylate does not facilitate expectoration. Streit E; Medici TC Eur Respir J; 1991 Jun; 4(6):718-22. PubMed ID: 1889499 [TBL] [Abstract][Full Text] [Related]
4. Expectorant action of bromhexine in chronic obstructive bronchitis. Hamilton WF; Palmer KN; Gent M Br Med J; 1970 Aug; 3(5717):260-1. PubMed ID: 4915361 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. Jackson IM; Barnes J; Cooksey P J Int Med Res; 1984; 12(3):198-206. PubMed ID: 6376210 [TBL] [Abstract][Full Text] [Related]
7. METHYLCYSTEINE HYDROCHLORIDE IN CHRONIC BRONCHITIS. MANN B; EDWARDS A; LAURRE M Br J Dis Chest; 1963 Oct; 57():192-6. PubMed ID: 14069562 [No Abstract] [Full Text] [Related]
8. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control. Aylward M; Maddock J; Dewland P Eur J Respir Dis Suppl; 1980; 111():81-9. PubMed ID: 7011835 [No Abstract] [Full Text] [Related]
9. Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. Rubin BK; Ramirez O; Ohar JA Chest; 1996 Feb; 109(2):348-52. PubMed ID: 8620704 [TBL] [Abstract][Full Text] [Related]
10. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial. Beeh KM; Beier J; Candler H; Wittig T Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515 [TBL] [Abstract][Full Text] [Related]
11. [Clinical and functional effects of domiodol and sobrerol in hypersecretory bronchopneumonias]. Finiguerra M; De Martini S; Negri L; Simonelli A Minerva Med; 1981 May; 72(21):1353-60. PubMed ID: 7015178 [TBL] [Abstract][Full Text] [Related]
12. The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. Petty TL Chest; 1990 Jan; 97(1):75-83. PubMed ID: 2403903 [TBL] [Abstract][Full Text] [Related]
13. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis. Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508 [TBL] [Abstract][Full Text] [Related]
14. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction. Edwards GF; Steel AE; Scott JK; Jordan JW Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027 [TBL] [Abstract][Full Text] [Related]
15. Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis. Puchelle E; Aug F; Polu JM Eur J Clin Pharmacol; 1978 Nov; 14(3):177-84. PubMed ID: 365537 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study). Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153 [TBL] [Abstract][Full Text] [Related]
18. A controlled trial of ambroxol in chronic bronchitis. Guyatt GH; Townsend M; Kazim F; Newhouse MT Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis]. Michnar M; Milanowski J Pneumonol Alergol Pol; 1996; 64 Suppl 1():90-6. PubMed ID: 9190245 [TBL] [Abstract][Full Text] [Related]
20. Improved sputum expectoration following a single dose of INS316 in patients with chronic bronchitis. Johnson FL; Donohue JF; Shaffer CL Chest; 2002 Dec; 122(6):2021-9. PubMed ID: 12475842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]